Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of postoperative bleeding with tranexamic acid or fibrin glue in subcapital femoral fracture surgery
2011-006278-15Phase 3Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Feb 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid and tachosil in Neck Of Femur Fracture and hip fracture (3 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Primary reduction in blood loss. Started Feb 2012; status: active.
02
Drugs
tranexamic acidtachosil
03
Conditions
Neck Of Femur Fracturehip fracture
Beyond the preview
Go deeper on 2011-006278-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006278-15.